Compare · BFLY vs PHG
BFLY vs PHG
Side-by-side comparison of Butterfly Network Inc. (BFLY) and Koninklijke Philips N.V. NY Registry Shares (PHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and PHG operate in Medical Electronics (Health Care), so they compete in similar markets.
- PHG is the larger of the two at $26.52B, about 14.0x BFLY ($1.90B).
- Over the past year, BFLY is up 253.9% and PHG is up 18.8% - BFLY leads by 235.1 points.
- BFLY has been more active in the news (12 items in the past 4 weeks vs 9 for PHG).
- PHG has more recent analyst coverage (22 ratings vs 8 for BFLY).
- Company
- Butterfly Network Inc.
- Koninklijke Philips N.V. NY Registry Shares
- Price
- $7.25-18.39%
- $26.95+0.62%
- Market cap
- $1.90B
- $26.52B
- 1M return
- +65.26%
- +0.79%
- 1Y return
- +253.90%
- +18.81%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 12
- 9
- Recent ratings
- 8
- 22
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest BFLY
- Director Schwartz Erica was granted 25,447 shares, increasing direct ownership by 7% to 401,699 units (SEC Form 4)
- Director Rothberg Jonathan M was granted 25,447 shares, increasing direct ownership by 0.88% to 2,905,699 units (SEC Form 4)
- Director Robbins Larry was granted 25,447 shares, increasing direct ownership by 7% to 390,952 units (SEC Form 4)
- Director Phanstiel S. Louise was granted 25,447 shares, increasing direct ownership by 7% to 390,952 units (SEC Form 4)
- Director Neubauer Caroll H was granted 25,447 shares, increasing direct ownership by 35% to 98,617 units (SEC Form 4)
- Director Edelman Elazer R was granted 25,447 shares, increasing direct ownership by 7% to 392,893 units (SEC Form 4)
- Butterfly Network Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Butterfly Network Provides Commentary on Midjourney Medical's Full Body Ultrasound Scanner Announcement
- 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
- Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
Latest PHG
- Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series
- NYSE Content Update: HUD Sec. Turner Highlights National Homeownership Month
- AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
- Philips Future Health Index 2026: AI is already saving clinicians time and delivering measurable impact in healthcare
- WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- Philips Lumea IPL 9000 Series and Philips Sonicare 6400 Electric Toothbrush Selected as Good Housekeeping 2026 Beauty Awards Winners
- Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
- Philips announces exchange ratio for 2025 dividend
- Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026